TESTBANK ws
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
ws ws ws ws ws ws ws
Author:Teri Moser Woo and Wendy L. Wright
ws ws ws ws ws ws ws
, TABLE OF CONTENT ws ws
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................... 4
ws ws ws ws ws ws ws ws ws ws
Chapter 2. Review of Basic Principles of Pharmacology ......................................................................................... 5
ws ws ws ws ws ws ws
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
ws ws ws ws
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
ws ws ws ws ws ws ws
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
ws ws ws ws
Chapter 6. An Introduction to Pharmacogenomics ................................................................................................ 19
ws ws ws ws ws
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
ws ws ws ws
Chapter 8. Herbal Therapies ................................................................................................................................. 28
ws ws ws
Chapter 9. Cannabis ............................................................................................................................................. 31
ws ws
Chapter 10. Pharmacoeconomics.......................................................................................................................... 35
ws ws
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
ws ws ws ws ws ws ws
Chapter 12. Drugs Affecting the Central Nervous System ..................................................................................... 45
ws ws ws ws ws ws ws
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ..................................................................... 53
ws ws ws ws ws ws ws ws
Chapter 14. Drugs Affecting the Respiratory System ............................................................................................ 61
ws ws ws ws ws ws
Chapter 15. Drugs Affecting the Hematological System........................................................................................ 65
ws ws ws ws ws ws
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
ws ws ws ws ws ws ws ws ws
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
ws ws ws ws ws ws ws
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
ws ws ws ws ws ws
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormones and Antidiabetic Drugs ......................... 80
w
s w
s ws ws ws w
s ws w
s ws ws ws
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs................................... 83
ws ws ws ws ws ws ws ws ws ws ws
Chapter 21. Drugs Affecting the Reproductive System.......................................................................................... 86
ws ws ws ws ws ws
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
ws ws ws ws ws ws ws
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
ws ws ws ws ws ws
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................... 101
ws ws ws ws ws ws ws
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ............................................................. 105
ws ws ws ws ws ws ws ws ws ws
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................... 108
ws ws ws ws ws ws ws
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
ws ws ws ws ws ws ws ws ws
Chapter 28. Anemia ............................................................................................................................................ 113
ws ws
Chapter 29. Anxiety and Depression ................................................................................................................... 116
ws ws ws ws
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
ws ws ws ws
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
ws ws ws ws
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
ws ws ws ws ws
Chapter 33. Contraception .................................................................................................................................. 127
ws ws
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
ws ws ws ws ws
Chapter 35. Dermatological Conditions .............................................................................................................. 134
ws ws ws
Chapter 36. Diabetes Management ..................................................................................................................... 138
ws ws ws
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
ws ws ws ws ws ws ws
Chapter 38. Headaches ....................................................................................................................................... 149
ws ws
Chapter 39. Heart Failure .................................................................................................................................... 153
ws ws ws
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
ws ws ws ws ws ws ws
Chapter 41. Menopausal Hormone Therapy........................................................................................................ 161
ws ws ws ws
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
ws ws
Chapter 43. Hypertension ................................................................................................................................... 169
ws ws
Chapter 44. Hyperthyroidism and Hypothyroidism ............................................................................................ 174
ws ws ws ws
Chapter 45. Obesity ............................................................................................................................................ 177
ws ws
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
ws ws ws ws ws ws ws
Chapter 47. Pneumonia....................................................................................................................................... 185
ws ws
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
ws ws ws ws ws ws
Chapter 49. Substance Use Disorders .................................................................................................................. 190
ws ws ws ws
Chapter 50. Tuberculosis .................................................................................................................................... 195
ws ws
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa ................. 197
w
s w
s w
s ws ws ws ws w
s ws ws ws ws
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
ws ws ws ws
Chapter 53. Women as Patients ........................................................................................................................... 203
ws ws ws ws
Chapter 54. Men as Patients ................................................................................................................................ 207
ws ws ws ws
Chapter 55. Pediatric Patients ............................................................................................................................. 209
ws ws ws
Chapter 57. Geriatric Patients ............................................................................................................................. 213
ws ws ws
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e w
s w
s ws ws Ch01
Chapter1.The Roleof the Advanced PracticeNurse as Prescriber
ws ws ws ws ws ws ws ws ws ws
MULTIPLE CHOICE ws
1. Nurse practitioner prescriptive authority is regulated by:
ws ws ws ws ws ws
A. The National Council of State Boards of Nursing ws ws ws ws ws ws ws
B. The U.S. Drug Enforcement Administration ws ws ws ws
C. The State Board of Nursing for each state ws ws ws ws ws ws ws
D. The State Board of Pharmacy ws ws ws ws
ANS: w s C PTS: w s w s 1
2. Thebenefitsto thepatient ofhaving anadvanced practice registerednurse (APRN)prescriber
w
s w
s ws w
s ws w
s ws w
s ws ws ws ws w
s
ws include:
A. Nursesknowmore about pharmacologythanotherprescribersbecausetheytakeit both
w
s w
s ws ws ws w
s ws w
s s
w w
s w
s ws
in their basic nursing program and in their APRN program.
ws ws ws ws ws ws ws ws ws ws
B. Nurses carefor thepatientfrom a holisticapproach and includethepatient in
ws w
s ws w
s ws ws ws w
s ws ws w
s w
s ws
decision-making regarding their care.
ws ws ws ws
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
ws ws ws ws ws ws ws ws ws s
w
D. APRNs areabletoprescribeindependentlyin allstates,whereas aphysician’s
ws w
s w
s w
s w
s w
s ws w
s w
s ws w
s
assistant needs to have a physician supervising their practice.
ws ws ws ws ws ws ws ws ws
ANS: w s B PTS: w s w s 1
3. Clinical judgment in prescribing includes: ws ws ws ws
A. Factoring in the cost to the patient of the medication prescribed ws ws ws ws ws ws ws ws ws ws
B. Always prescribing the newest medication available for the diseaseprocessws ws ws ws ws ws ws ws s
w
C. Handing out drug samples to poor patients ws ws ws ws ws ws
D. Prescribing all generic medications to cutcosts ws ws ws ws ws w
s
ANS: w s A PTS: w s w s 1
4. The process for choosing an effective drug for a disorderincludes:
ws ws ws ws ws ws ws ws ws w
s
A. Asking the patient what drug they think would work best for them ws ws ws ws ws ws ws ws ws ws ws
B. Consulting nationally recognized guidelines for diseasemanagement ws ws ws ws ws s
w
C. Prescribingmedicationsthat are available as samples beforewriting a prescription ws ws ws ws ws ws ws w
s ws ws
D. Following U.S. Drug Enforcement Administration guidelines forprescribing ws ws ws ws ws ws s
w
ANS: w s B PTS: w s w s 1
5. Nonintentional nonadherence of drug therapy may occur due to: ws ws ws ws ws ws ws ws
A. Belief that medication does not work ws ws ws ws ws
B. Adverse drug reactions ws ws
C. Chronic conditions that require dailytherapy ws ws ws ws s
w
D. Forgetfulness ordistraction ws s
w
ANS: w s D PTS: w s w s 1
PharmacotherapeuticsforAdvanced PracticeNurse Prescribers, 6th Edition
ws ws ws ws ws ws ws
Author:Teri Moser Woo and Wendy L. Wright
ws ws ws ws ws ws ws
, TABLE OF CONTENT ws ws
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber ........................................................................... 4
ws ws ws ws ws ws ws ws ws ws
Chapter 2. Review of Basic Principles of Pharmacology ......................................................................................... 5
ws ws ws ws ws ws ws
Chapter 3. Rational Drug Selection ....................................................................................................................... 11
ws ws ws ws
Chapter 4. Legal and Professional Issues in Prescribing ......................................................................................... 14
ws ws ws ws ws ws ws
Chapter 5. Adverse Drug Reactions ...................................................................................................................... 16
ws ws ws ws
Chapter 6. An Introduction to Pharmacogenomics ................................................................................................ 19
ws ws ws ws ws
Chapter 7. Nutrition and Nutraceuticals ................................................................................................................ 22
ws ws ws ws
Chapter 8. Herbal Therapies ................................................................................................................................. 28
ws ws ws
Chapter 9. Cannabis ............................................................................................................................................. 31
ws ws
Chapter 10. Pharmacoeconomics.......................................................................................................................... 35
ws ws
Chapter 11. Drugs Affecting the Autonomic Nervous System ............................................................................... 38
ws ws ws ws ws ws ws
Chapter 12. Drugs Affecting the Central Nervous System ..................................................................................... 45
ws ws ws ws ws ws ws
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ..................................................................... 53
ws ws ws ws ws ws ws ws
Chapter 14. Drugs Affecting the Respiratory System ............................................................................................ 61
ws ws ws ws ws ws
Chapter 15. Drugs Affecting the Hematological System........................................................................................ 65
ws ws ws ws ws ws
Chapter16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins ............................................... 69
ws ws ws ws ws ws ws ws ws
Chapter17. Drugs Affecting the Immune System: Immunomodulators ................................................................. 75
ws ws ws ws ws ws ws
Chapter 18. Drugs Affecting the Gastrointestinal System ...................................................................................... 77
ws ws ws ws ws ws
Chapter19.DrugsAffectingtheEndocrineSystem:PancreaticHormones and Antidiabetic Drugs ......................... 80
w
s w
s ws ws ws w
s ws w
s ws ws ws
Chapter20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs................................... 83
ws ws ws ws ws ws ws ws ws ws ws
Chapter 21. Drugs Affecting the Reproductive System.......................................................................................... 86
ws ws ws ws ws ws
Chapter 22. Drugs Affecting the Bones and Joints ................................................................................................. 92
ws ws ws ws ws ws ws
Chapter 23. Drugs Affecting the Integumentary System ........................................................................................ 96
ws ws ws ws ws ws
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................... 101
ws ws ws ws ws ws ws
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ............................................................. 105
ws ws ws ws ws ws ws ws ws ws
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................... 108
ws ws ws ws ws ws ws
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ....................................................................................... 111
ws ws ws ws ws ws ws ws ws
Chapter 28. Anemia ............................................................................................................................................ 113
ws ws
Chapter 29. Anxiety and Depression ................................................................................................................... 116
ws ws ws ws
Chapter 30. Attention Deficit-Hyperactivity Disorder ........................................................................................ 120
ws ws ws ws
Chapter 31. Asthma and Allergy ......................................................................................................................... 122
ws ws ws ws
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................... 125
ws ws ws ws ws
Chapter 33. Contraception .................................................................................................................................. 127
ws ws
Chapter 34. COVID-19: Acute and Chronic ........................................................................................................ 130
ws ws ws ws ws
Chapter 35. Dermatological Conditions .............................................................................................................. 134
ws ws ws
Chapter 36. Diabetes Management ..................................................................................................................... 138
ws ws ws
Chapter37. Gastroesophageal Reflux and Peptic Ulcer Disease .......................................................................... 146
ws ws ws ws ws ws ws
Chapter 38. Headaches ....................................................................................................................................... 149
ws ws
Chapter 39. Heart Failure .................................................................................................................................... 153
ws ws ws
Chapter40. HIV Disease and Acquired Immunodeficiency Syndrome ................................................................ 158
ws ws ws ws ws ws ws
Chapter 41. Menopausal Hormone Therapy........................................................................................................ 161
ws ws ws ws
,Chapter 42. Hyperlipidemia ............................................................................................................................... 164
ws ws
Chapter 43. Hypertension ................................................................................................................................... 169
ws ws
Chapter 44. Hyperthyroidism and Hypothyroidism ............................................................................................ 174
ws ws ws ws
Chapter 45. Obesity ............................................................................................................................................ 177
ws ws
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................... 181
ws ws ws ws ws ws ws
Chapter 47. Pneumonia....................................................................................................................................... 185
ws ws
Chapter 48. Sexually Transmitted Diseases and Vaginitis ................................................................................... 187
ws ws ws ws ws ws
Chapter 49. Substance Use Disorders .................................................................................................................. 190
ws ws ws ws
Chapter 50. Tuberculosis .................................................................................................................................... 195
ws ws
Chapter51.UpperRespiratoryTract Infection, Pharyngitis,Sinusitis,OtitisMedia, and Otitis Externa ................. 197
w
s w
s w
s ws ws ws ws w
s ws ws ws ws
Chapter 52. Urinary Tract Infections ................................................................................................................... 200
ws ws ws ws
Chapter 53. Women as Patients ........................................................................................................................... 203
ws ws ws ws
Chapter 54. Men as Patients ................................................................................................................................ 207
ws ws ws ws
Chapter 55. Pediatric Patients ............................................................................................................................. 209
ws ws ws
Chapter 57. Geriatric Patients ............................................................................................................................. 213
ws ws ws
, Woo 1
PharmacotherapeuticsforAPN Prescribers,6e w
s w
s ws ws Ch01
Chapter1.The Roleof the Advanced PracticeNurse as Prescriber
ws ws ws ws ws ws ws ws ws ws
MULTIPLE CHOICE ws
1. Nurse practitioner prescriptive authority is regulated by:
ws ws ws ws ws ws
A. The National Council of State Boards of Nursing ws ws ws ws ws ws ws
B. The U.S. Drug Enforcement Administration ws ws ws ws
C. The State Board of Nursing for each state ws ws ws ws ws ws ws
D. The State Board of Pharmacy ws ws ws ws
ANS: w s C PTS: w s w s 1
2. Thebenefitsto thepatient ofhaving anadvanced practice registerednurse (APRN)prescriber
w
s w
s ws w
s ws w
s ws w
s ws ws ws ws w
s
ws include:
A. Nursesknowmore about pharmacologythanotherprescribersbecausetheytakeit both
w
s w
s ws ws ws w
s ws w
s s
w w
s w
s ws
in their basic nursing program and in their APRN program.
ws ws ws ws ws ws ws ws ws ws
B. Nurses carefor thepatientfrom a holisticapproach and includethepatient in
ws w
s ws w
s ws ws ws w
s ws ws w
s w
s ws
decision-making regarding their care.
ws ws ws ws
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
ws ws ws ws ws ws ws ws ws s
w
D. APRNs areabletoprescribeindependentlyin allstates,whereas aphysician’s
ws w
s w
s w
s w
s w
s ws w
s w
s ws w
s
assistant needs to have a physician supervising their practice.
ws ws ws ws ws ws ws ws ws
ANS: w s B PTS: w s w s 1
3. Clinical judgment in prescribing includes: ws ws ws ws
A. Factoring in the cost to the patient of the medication prescribed ws ws ws ws ws ws ws ws ws ws
B. Always prescribing the newest medication available for the diseaseprocessws ws ws ws ws ws ws ws s
w
C. Handing out drug samples to poor patients ws ws ws ws ws ws
D. Prescribing all generic medications to cutcosts ws ws ws ws ws w
s
ANS: w s A PTS: w s w s 1
4. The process for choosing an effective drug for a disorderincludes:
ws ws ws ws ws ws ws ws ws w
s
A. Asking the patient what drug they think would work best for them ws ws ws ws ws ws ws ws ws ws ws
B. Consulting nationally recognized guidelines for diseasemanagement ws ws ws ws ws s
w
C. Prescribingmedicationsthat are available as samples beforewriting a prescription ws ws ws ws ws ws ws w
s ws ws
D. Following U.S. Drug Enforcement Administration guidelines forprescribing ws ws ws ws ws ws s
w
ANS: w s B PTS: w s w s 1
5. Nonintentional nonadherence of drug therapy may occur due to: ws ws ws ws ws ws ws ws
A. Belief that medication does not work ws ws ws ws ws
B. Adverse drug reactions ws ws
C. Chronic conditions that require dailytherapy ws ws ws ws s
w
D. Forgetfulness ordistraction ws s
w
ANS: w s D PTS: w s w s 1
